Josep Redón Selected Research

Josep Redón Research Topics

Disease

13	Hypertension (High Blood Pressure) 10/2020 - 05/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 11/2007
6	Obesity 12/2023 - 09/2008
3	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2009
3	Heart Failure 12/2020 - 04/2010
3	Essential Hypertension 01/2009 - 04/2002
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2014
2	COVID-19 01/2021 - 01/2021
2	Stroke (Strokes) 12/2020 - 04/2010
2	Diabetes Mellitus 10/2020 - 01/2009
2	Atrial Fibrillation 08/2010 - 08/2010
1	Insulin Resistance 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Peripheral Arterial Disease 12/2020
1	Pulmonary Embolism 10/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2020
1	Left Ventricular Dysfunction 01/2019
1	Inflammation (Inflammations) 01/2017
1	Chronic Renal Insufficiency 02/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2011
1	Weight Gain 01/2009
1	Overweight 09/2008
1	Renal Insufficiency (Renal Failure) 01/2008
1	Atherosclerosis 08/2007
1	Mixed Connective Tissue Disease (MCTD) 06/2007
1	Hepatitis 06/2007
1	Autoimmune Diseases (Autoimmune Disease) 06/2007
1	Liver Diseases (Liver Disease) 06/2007
1	Thrombocytopenia (Thrombopenia) 03/2003
1	Leukoencephalopathies 05/2002
1	Progressive Multifocal Leukoencephalopathy 05/2002
1	Hypertensive Crisis 05/2002

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2022 - 03/2008
4	Antihypertensive Agents (Antihypertensives)IBA 01/2009 - 04/2002
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2009
3	HDL CholesterolIBA 01/2022 - 09/2009
3	oxidized low density lipoproteinIBA 01/2022 - 01/2008
3	AntioxidantsIBA 03/2011 - 05/2003
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2008
2	CholesterolIBA 01/2022 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2007
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2013 - 01/2013
2	EnzymesIBA 03/2011 - 06/2007
2	AnticoagulantsIBA 08/2010 - 08/2010
2	Enalapril FDA LinkGeneric 04/2010 - 01/2009
2	NitrendipineIBA 04/2010 - 01/2009
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2023
1	Glucagon-Like Peptide ReceptorsIBA 12/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2023
1	MetalsIBA 01/2023
1	VLDL LipoproteinsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	CytokinesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	InterferonsIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	CreatinineIBA 12/2020
1	omega-Chloroacetophenone (Mace)IBA 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020
1	dineopentyl glutamateIBA 10/2020
1	Amino Acids FDA Link 01/2019
1	AcidsIBA 01/2019
1	Branched-Chain Amino AcidsIBA 01/2019
1	Transfer RNA (tRNA)IBA 01/2019
1	Taurine FDA Link 01/2019
1	TabletsIBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Cardiovascular AgentsIBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2013
1	PlacebosIBA 04/2010
1	DiureticsIBA 01/2009
1	Blood Glucose (Blood Sugar)IBA 01/2009
1	Uric Acid (Urate)IBA 11/2007
1	Superoxides (Superoxide)IBA 08/2007
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2007
1	Genetic Markers (Genetic Marker)IBA 08/2007
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2007
1	Antimalarials (Antimalarial Agents)IBA 06/2007
1	8-Hydroxy-2'-DeoxyguanosineIBA 05/2007
1	SodiumIBA 10/2005
1	Ouabain (G Strophanthin)IBA 10/2005
1	PotassiumIBA 10/2005
1	adducinIBA 10/2005
1	Adenosine Triphosphatases (ATPase)IBA 10/2005
1	Levodopa (L Dopa)FDA LinkGeneric 03/2003
1	Indinavir (Crixivan)FDA Link 05/2002

Therapy/Procedure

8	Therapeutics 04/2023 - 09/2008
1	Secondary Prevention 10/2019
1	Highly Active Antiretroviral Therapy (HAART) 05/2002